FIbrosis and Steatosis in Patients With Psychiatric Illness

CompletedOBSERVATIONAL
Enrollment

385

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

July 12, 2021

Conditions
Severe Bipolar I Disorder (Diagnosis)Bipolar I Disorder, Most Recent Episode Mixed, in RemissionDepression Psychotic FeatureMood-Incongruent Delusion
Interventions
DIAGNOSTIC_TEST

Fibroscan

"Performing FibroScan :~The patient is positioned supine, with the right arm in maximum abduction to clear the intercostal spaces.The measurement itself is performed on the right lobe of the liver via the intercostal (intersection of the mid-axillary line and the xiphoid process) using a dedicated probe (3.5 MHz) after application of a conduction gel to the skin. FibroScan® examinations are carried out by personnel trained in the use of the device.This training is specific and validated by the device's manufacturer manufacturer, EchosensTM (Paris). Ten valid measurements at the same measurement point in the right liver must be be performed, with an interquartile range/median ratio ≤ 30 (required only if the elastometry value is \> 7.1 KPa."

Trial Locations (1)

87025

Centre Hospitalier Esquirol, Limoges

All Listed Sponsors
lead

Centre Hospitalier Esquirol

OTHER

NCT05965232 - FIbrosis and Steatosis in Patients With Psychiatric Illness | Biotech Hunter | Biotech Hunter